L 134/2
EN
Official Journal of the European Union
11.5.2022
(7)
Following an application from Tchibo GmbH, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on the scientific substantiation of a health claim related to Coffee C21 and the protection of DNA from strand breaks (Question No EFSA-Q-2019-00423).
The claim proposed by the applicant was worded as follows: ‘regular consumption of Coffee C21 contributes to the maintenance of DNA integrity in cells of the body’.
(8)
The Commission, the Member States and the applicant received the scientific opinion (3) on that claim from the Authority, which concluded that, on the basis of the data presented, a cause and effect relationship has not been established between the consumption of Coffee C21 and the protection of DNA from strand breaks.
Accordingly, as the health claim does not comply with the requirements of Regulation (EC) No 1924/2006 for the inclusion in the Union list of permitted claims, it should not be authorised.
(9)
Following an application from NattoPharma ASA, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on the scientific substantiation of a health claim related to MenaQ7® and the maintenance of the elastic properties of the arteries (Question No EFSA-Q2019-00229).
The claim proposed by the applicant was worded as follows: ‘MenaQ7®, vitamin K2 as menaquinone-7, improves arterial stiffness’.
(10)
The Commission, the Member States and the applicant received the scientific opinion (4) on that claim from the Authority, which concluded that, on the basis of the data presented, a cause and effect relationship has not been established between the consumption of MenaQ7® and the maintenance of the elastic properties of the arteries.
Accordingly, as the health claim does not comply with the requirements of Regulation (EC) No 1924/2006 for the inclusion in the Union list of permitted claims, it should not be authorised.
(11)
The comments from DuPont Nutrition Biosciences ApS and Tchibo GmbH received by the Commission pursuant to Article 16(6) of Regulation (EC) No 1924/2006, have been considered when adopting this Regulation.
(12)
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
HAS ADOPTED THIS REGULATION:
Article 1 The health claims listed in the Annex to this Regulation shall not be included in the Union list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006.
Article 2 This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 10 May 2022.
For the Commission The President Ursula VON DER LEYEN
(3) EFSA Journal 2020;18(3):6055.
(4) EFSA Journal 2020;18(1):5949.